Marijuana startups are mimicking tech companies’ style of marketing and branding.
Click the image (courtesy Business Insider) for the entire story.
Goal: Share genetic data without risk of hacking or infringement of patients’ privacy.
Tap the image for the full story, published on “coindesk” August, 2018.
Major Biotech ETFs Had Lackluster Performance in the Past Month
All three major biotechnology ETFs—the SPDR S&P Biotech ETF (XBI), the iShares NASDAQ Biotechnology Index (IBB), and the ProShares Ultra Nasdaq Biotechnology ETF (BIB)—have posted returns of ~1% in last month, starting on August 10. That compares unfavorably with the performance of the SPDR S&P 500 ETF (SPY), which returned ~1.7% in the same period.
Source: Major Biotech ETFs Had Lackluster Performance in the Past Month
Theranos finally shutting down
Creative Biotech has been covering the blood testing industry and scams infesting it for a couple of years. Tap the image to go to the “In-Focus” page for the complete story.
